Shire to Buy ViroPharma for Around $4.2 Billion

Shire to Buy ViroPharma for Around $4.2 Billion

In order to establish itself in providing treatments for rare disease, Shire Plc is going to buy ViroPharma Inc. The deal has taken place for around $4.2 billion and Shire will be paying $50 a share and that too in cash.

The recent deal is considered to be the third one for Shire. The purchase will allow Shire to have an access to Cinryze, a medicine meant for the treatment of hereditary angioedema, an inflammatory condition.

The company has said that the deal will help in raising Shire's earnings per share. In fact, as the announcement of the deal was made, Shire was able to witness a rise of 3.5% amounting to 2,894 pence.

"It's a deal that fits with our strategy of increased focus on high-growth speciality markets, particularly rare diseases", said Flemming Ornskov, CEO of Shire.

Ornskov talked about Cinryze and said that it will act a grown engine for the company. Moreover, it is an attractive drug that will prove beneficial for the company.

In addition, it has been revealed that Shire has announced that it has been planning to stop a number of programs that are taking place out of the field of rare disease.


FrenchTribune Specials

Alaska Fisheries are at Risk of ocean acidification: NOAA Warning

According to a latest research led by NOAA, acidification of oceans is bringing changes in waters that are important to commercial fisheries in Alaska.

Many marine fisheries of Alaska are in those waters that are experiencing ocean acidification at present and the study shows that they will witness more of it in the near future.

...

Most Popular

EMI Sold to Universal, Sony

Music industry giant group EMI would be divided in to...

Healthy honeybees of Newfoundland are of an increasing...

Dinosaurs Died Due to Asteroid Impact

A new study, published in the latest issue of Biological...

HTC to Launch Windows Phone with 1280*800 Resolution Support

After launching HTC 8S and HTC 8X in 2012, Taiwanese...

Poll

Can Greece Come out of Economic Problems: